Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 33Neoplasms 25Prostatic Neoplasms 16Colorectal Neoplasms 13Lung Neoplasms 11Multiple Myeloma 9Head and Neck Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 6Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Hematologic Neoplasms 5Gastrointestinal Neoplasms 5Advanced Cancer 5Uterine Cervical Neoplasms 4Smoking Cessation 4Ovarian Neoplasms 4Melanoma 4Leukemia 4Colonic Neoplasms 4Anxiety Disorders 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Rectal Neoplasms 3Neoplasms, Plasma Cell 3Motor Activity 3Lymphoma, Follicular 3Lymphedema 3

Interventions

enzalutamide 6radium Ra 223 dichloride 5Docetaxel 2Abiraterone Acetate 2zimberelimab 1xentuzumab 1sacituzumab govitecan 1quemliclustat 1pembrolizumab 1atezolizumab 1apalutamide 1Standard of Care 1Radium-223 1Prednisone 1Nivolumab 1Ipilimumab 1Drug Therapy 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms, Castration-Resistant × Standard of Care × Clear all
NCT03017417 2024-07-18

COMRADE

Sheffield Teaching Hospitals NHS Foundation Trust

Phase NA Completed
31 enrolled
Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡